Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational studyAlexander Avidan, Spyros D. Mentzelopoulos, Joseph L. Nates et al.|The Lancet Respiratory Medicine|2021Cited by 169
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialAlexander P. J. Vlaar, Martin Witzenrath, Pieter van Paassen et al.|The Lancet Respiratory Medicine|2022Cited by 143
Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 ScoreOtávio T. Ranzani, Simon Oczkowski, Mervyn Singer et al.|JAMA|2025Cited by 81